Legionella Testing Market Updates

Legionella Testing Market size was valued at USD 320.5 Million in 2023 and is poised to grow from USD 347.1 Million in 2024 to USD 657.02 Million by 2032, growing at a CAGR of 0.083 during the forecast period (2025-2032).

Global legionella testing market competitive scene is formed with several top brands leading to introduction of new ideas and techniques. Major multinationals comprise of Thermo Fisher Scientific which deals in sophisticated PCR-based technologies, IDEXX Laboratories that has become famous for their quick antigen tests as well as Bio-Rad Laboratories which sell variety of diagnostic products. To gain a considerable portion of the expanding market, these firms put emphasis on improving the precision of testing, broadening product lines and conforming to stringent regulatory requirements. 'Thermo Fisher Scientific  ', 'Merck KGAA  ', 'Bio-Rad Laboratories  ', 'IDEXX Laboratories  ', 'Biomerieux SA  ', 'Becton, Dickinson and Company  ', 'Eurofins Scientific  ', 'Takara Bio  ', 'Eiken Chemical  ', 'Qiagen  ', 'Genomadix  ', 'Phigenics, Llc  ', 'Hydrosense  ', 'Luminultra technologies  ', 'Bioalert solutions  ', 'Aquacert  ', 'Sens solutions  ', 'Roche Diagnostics  ', 'Hologic  ', 'Quidel Corporation'

Increasing Incidence of Legionnaires’ Disease

Rising Adoption of Real-Time Monitoring Solutions: The global legionella testing market is inclining towards real-time monitoring solutions. Cutting-edge technologies make it easier for water systems to be constantly monitored thereby notifying one early enough and lessening the possibilities of outbreaks. It thus facilitates a proactive approach in the management that complies with strict safety guidelines.

North America runs the global lgionella testing market due to the strict government regulations that exist, advanced healthcare system and increased awareness on waterborne diseases. Thus, demand for legionella testing has been driven by strong environmental monitoring programs and stringent water system safety standards across this region, especially in hospitals, hotels as well as public buildings. Moreover, the market is boosted by the increase in Legionnaires' disease cases and the use of advanced diagnostic technologies such as PCR and IVD testing that are now so common. Furthermore, the presence of major industry players along with continuous innovations in testing methods has also enabled North America to maintain its top position in legionella testing.